Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription 19.05.2025 3 Am Heart J 3 Am J Cardiol 1 Am J Emerg Med 1 Angiology 1 Ann Thorac Surg 1 Can J Cardiol 2 Circ Cardiovasc Interv 1 Circ Cardiovasc Qual Outcomes 5 Circulation 1 Clin Cardiol 1 Eur Heart J 1 Int J Cardiol 1 J Am Coll Cardiol 2 J Cardiovasc Pharmacol 2 J Thromb Haemost 1 JAMA 1 Lancet 1 Mol Cell Biochem 2 Prog Cardiovasc Dis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. CARULLI E, McGarvey M, Chabok M, Panoulas V, et al
   Corrigendum to ;;Transcoronary cooling and dilution for cardioprotection during revascularisation for ST-segment elevation myocardial infarction: design and rationale of the STEMI-Cool study''. [Am Heart J. 2025:282:40-50].
   Am Heart J. 2025;288:89.
   PubMed        
   
   
2. MESSINGER MC, Ashburn NP, Chait JS, Snavely AC, et al
   Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States.
   Am Heart J. 2025 May 13:S0002-8703(25)00157-7. doi: 10.1016/j.ahj.2025.
   PubMed         Abstract available
   
   
3. JAMES S, Christoffersen AD, David JP, Hacker M, et al
   Effect of Once-Weekly Subcutaneous Semaglutide on Arterial Inflammation in People with Type 2 Diabetes and Cardiovascular Disease Using PET-MRI: Primary Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
   Am Heart J. 2025 May 7:S0002-8703(25)00156-5. doi: 10.1016/j.ahj.2025.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

4. AKBAR UA, Taha MB, Arshad HB, Patel KV, et al
   Young Adults Undergoing Percutaneous Coronary Intervention for Myocardial Infarction in the United States, 2011-2023.
   Am J Cardiol. 2025 May 10:S0002-9149(25)00295.
   PubMed         Abstract available
   
   
5. LALANI C, Sharma RK, Sevilla-Cazes J, Kennedy K, et al
   Outcomes of Percutaneous Coronary Interventions Following Transcatheter Aortic Valve Replacement: Insights from the CathPCI Registry.
   Am J Cardiol. 2025 May 10:S0002-9149(25)00294.
   PubMed         Abstract available
   
   
6. MARK DG, Huang J, Lee KK, Sax DR, et al
   Implementation of a High-Sensitivity Cardiac Troponin Assay and Diagnostic Protocol for Suspected Acute Coronary Syndrome.
   Am J Cardiol. 2025 May 8:S0002-9149(25)00292.
   PubMed         Abstract available
   
   

   
   Am J Emerg Med

7. CAMP S, Elhamdani A, Zinabu S, McGinnis P, et al
   Serum troponin testing and adverse cardiovascular outcomes in supraventricular tachycardia: A retrospective study from TriNetX.
   Am J Emerg Med. 2025;95:7-15.
   PubMed         Abstract available
   
   

   
   Angiology

8. CAP M, Karaduman M, Zhou T, Erdogan E, et al
   An Automated User-friendly Software for Fast Computation of Blood Flow Velocity From Coronary Angiographic Images.
   Angiology. 2025 May 15:33197251338474. doi: 10.1177/00033197251338474.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

9. LAMY A
   The Downfall of RITA as a Second Conduit in Coronary Artery Bypass Surgery.
   Ann Thorac Surg. 2025 May 8:S0003-4975(25)00402.
   PubMed        
   
   

   
   Can J Cardiol

10. WU Y, Liu J, Du X, Li M, et al
    Prognostic Value of Angiography-derived Index of Microcirculatory Resistance in Patients with diabetes and ST-Segment Elevation Myocardial Infarction.
    Can J Cardiol. 2025 May 9:S0828-282X(25)00334-4. doi: 10.1016/j.cjca.2025.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

11. ISHIKAWA T, Natsuaki M, Watanabe H, Morimoto T, et al
    Aspirin-Free Strategy for PCI in Patients With High Bleeding Risk With or Without Acute Coronary Syndrome: A Subgroup Analysis From the STOPDAPT-3 Trial.
    Circ Cardiovasc Interv. 2025 May 14:e015197.
    PubMed         Abstract available
    
    
12. DEMIR OM, Sinha A, Rahman H, Ryan M, et al
    Pressure-Derived Indices in the Left Main Coronary Artery: Insights From Comprehensive In Vivo Hemodynamic Studies of Diseased and Unobstructed Vessels.
    Circ Cardiovasc Interv. 2025 May 12:e015320.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Qual Outcomes

13. SAYED A, Michos ED, Navar AM, Virani SS, et al
    Global Sociodemographic Disparities in Ischemic Heart Disease Mortality According to Sex, 1980 to 2021.
    Circ Cardiovasc Qual Outcomes. 2025 May 13:e011648.
    PubMed         Abstract available
    
    

    
    Circulation

14. SATTAR N, Weerakkody GJ, McGuire DK, Kosiborod MN, et al
    The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4.
    Circulation. 2025;151:1430-1432.
    PubMed        
    
    
15. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
    Correction to: Sedentary Behavior and Light-intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
    Circulation. 2025;151:e1000.
    PubMed        
    
    
16. BOHULA EA, Landzberg MJ, Menon V, Alviar CL, et al
    Palliative and End-of-Life Care During Critical Cardiovascular Illness: A Scientific Statement From the American Heart Association.
    Circulation. 2025 May 15. doi: 10.1161/CIR.0000000000001334.
    PubMed         Abstract available
    
    
17. REITAN C, Andell P, Hofmann R, Jernberg T, et al
    Response by Reitan et al to Letter Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
    Circulation. 2025;151:e988-e989.
    PubMed        
    
    
18. ZHANG Z, Yang X, Zhang Z
    Letter by Zhang et al Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
    Circulation. 2025;151:e986-e987.
    PubMed        
    
    

    
    Clin Cardiol

19. OZKAN U, Budak M, Gurdogan M, Ozturk G, et al
    KCNQ1 Polymorphism in the Context of Ischemic Cardiomyopathy: A Potential Key to Decision-Making for Device Implantation.
    Clin Cardiol. 2025;48:e70148.
    PubMed         Abstract available
    
    

    
    Eur Heart J

20. COYLE M, McEvoy JW
    Age-specific troponin thresholds: considerations for the fifth universal definition of myocardial infarction.
    Eur Heart J. 2025 May 9:ehaf308. doi: 10.1093.
    PubMed        
    
    

    
    Int J Cardiol

21. ZARRAR M
    Growth Differentiation Factor 15 and Empagliflozin in acute myocardial infarction: Correspondence.
    Int J Cardiol. 2025 May 11:133365. doi: 10.1016/j.ijcard.2025.133365.
    PubMed        
    
    

    
    J Am Coll Cardiol

22. SCHWARTZ GG, Cobbaert CM
    Plozasiran and Apolipoprotein C-III Inhibition: Lipoprotein Particle Insights and Cardiovascular Implications.
    J Am Coll Cardiol. 2025;85:1855-1857.
    PubMed        
    
    

    
    J Cardiovasc Pharmacol

23. BAHARDOUST M, Yarahmadi D, Aghakhani Z, Mahdi Kakoienejad M, et al
    Comparison of short-term treatment with atorvastatin versus rosuvastatin for preventing contrast-associated acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention: a systematic review and meta-analysis.
    J Cardiovasc Pharmacol. 2025 May 14. doi: 10.1097/FJC.0000000000001718.
    PubMed         Abstract available
    
    
24. BURNETT H, Cichewicz A, Natani H, Bhowmik D, et al
    Comparative Efficacy of Non-Statin Lipid-Lowering Therapies in Patients With Hypercholesterolemia at Increased Cardiovascular Risk: An Updated Network Meta-Analysis.
    J Cardiovasc Pharmacol. 2025 May 13. doi: 10.1097/FJC.0000000000001712.
    PubMed         Abstract available
    
    

    
    J Thromb Haemost

25. VAN EDOM CJ, Fiorelli F, Balthazar T, Monteagudo-Vela M, et al
    Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock.
    J Thromb Haemost. 2025;23:1810-1816.
    PubMed         Abstract available
    
    
26. MOUSSA MD, Abou-Arab O, Staessens S, Jungling M, et al
    Comparison of the effects of phosphorylcholin versus heparin-based surface coating on clinical and histologic outcomes during veno-arterial extracorporeal membrane oxygenation support: a propensity score weighted analysis.
    J Thromb Haemost. 2025;23:1879-1892.
    PubMed         Abstract available
    
    

    
    JAMA

27. GARRISON SR, Bakal JA, Kolber MR, Korownyk CS, et al
    Antihypertensive Medication Timing and Cardiovascular Events and Death: The BedMed Randomized Clinical Trial.
    JAMA. 2025 May 12:e254390. doi: 10.1001/jama.2025.4390.
    PubMed         Abstract available
    
    

    
    Lancet

28. LEE SJ, Kim BK
    Obicetrapib-ezetimibe combination therapy for patients with atherosclerotic cardiovascular disease.
    Lancet. 2025 May 5:S0140-6736(25)00827-X. doi: 10.1016/S0140-6736(25)00827.
    PubMed        
    
    

    
    Mol Cell Biochem

29. CAO X, Wang T, Mu G, Chen Y, et al
    Dysregulated homocysteine metabolism and cardiovascular disease and clinical treatments.
    Mol Cell Biochem. 2025 May 10. doi: 10.1007/s11010-025-05284.
    PubMed         Abstract available
    
    

    
    Prog Cardiovasc Dis

30. ROULEAU CR, Garland SN
    A social ecological perspective on interventions to address short sleep duration in adults with coronary heart disease.
    Prog Cardiovasc Dis. 2025 May 13:S0033-0620(25)00074.
    PubMed         Abstract available
    
    
31. TOTH PP, Banach M
    No second chances: Cardiovascular death is the most frequent incident event among patients with coronary artery calcium.
    Prog Cardiovasc Dis. 2025 May 13:S0033-0620(25)00073.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.